<DOC>
	<DOC>NCT00627952</DOC>
	<brief_summary>Eight-week multi-national, multicenter, randomized, double blind, active control, two arms, parallel groups study with a 4-week single drug treatment (manidipine or amlodipine) phase followed by a 4-week combination treatment (manidipine + delapril or amlodipine + delapril) phase.</brief_summary>
	<brief_title>A Study to Evaluate the Effects of Manidipine Versus Amlodipine and the Combination of Manidipine Plus Delapril Versus Amlodipine Plus Delapril on Intraglomerular Pressure in Hypertensive Patients</brief_title>
	<detailed_description>The aim of the current study is to assess the effect of a 4-week single drug treatment with manidipine or amlodipine and a 4-week combination treatment with manidipine plus delapril or amlodipine plus delapril on intraglomerular pressure in subjects with hypertension.</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Delapril</mesh_term>
	<mesh_term>Manidipine</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>male or female patients aged 18 years or older mild to moderate hypertension (systolic blood pressure &gt; 139 mmHg or diastolic blood pressure &gt; 89 mmHg) secondary form of arterial hypertension severe hypertension (systolic blood pressure &gt; 179 mmHg or diastolic blood pressure &gt; 109 mmHg) pregnant or lactating women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>hypertension</keyword>
	<keyword>intraglomerular pressure</keyword>
</DOC>